Ginkgo Bioworks is down -13.5%, or -$1.26 to $8.10.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNA:
- Upcoming Stock Splits This Week (August 19 to August 23) – Stay Invested
- Ginkgo Bioworks stilll sees 2024 revenue $170M-$190M, consensus $179.5M
- Ginkgo Bioworks reports Q2 EPS (11c), consensus (8c)
- Ginkgo Bioworks options imply 40.5% move in share price post-earnings
- Ginkgo Bioworks price target lowered to 25c from 80c at BofA